Founded 1984, Boston-based. Managing c.$46bn AUM (post Fund XII $9.5bn close, Oct 2024). 225+ professionals incl. 100+ investment team. Portfolio: 550+ cos across tech, healthcare, growth services. Exits: 175+ IPOs, 250+ M&A. Recent: Dreampath Diagnostics (healthcare tech), RIS Rx (pharma tech), Simply.TV (streaming), Veriforce (contractor mgmt). Global offices: Boston, Menlo Park, New York, London, Luxembourg. Peak Performance Group delivers on-demand ops, M&A, talent, data science support.
Investment Focus
Investment Thesis
Growth equity globally targeting profitable, category-leading companies. Tech: software, semiconductors, infrastructure. Healthcare: digital workflows, clinical tech, med devices. Growth products & services: fintech, business services, consumer. Cheque: $10-500m (incl. $75-500m for Fund XII). Stages: expansion through growth buyouts, both minority & majority. Avoid: early-stage ventures, loss-making cos. Geography: North America, Europe expanding. Value-add: Peak Performance Group (ops, M&A, talent, tech), 40-yr track record, 550+ portfolio co.
Interested in connecting?
Visit their website or reach out directly.